About Genesys Regional Medical Center
"In Central Michigan, Ascension Genesys Hospital is a full-service hospital with 24/7 emergency care and surgical specialists. Our doctors and care teams deliver personalized care for serious and life-threatening injuries and illnesses. We listen to quickly understand your health needs to deliver care that is right for you. We offer a wide range for specialty care services from heart and lung care to cancer, brain and spine and orthopedic care. Our OB-GYN maternity care services and Birthing Center offer a personalized birthing experience. At Ascension Genesys Hospital, we deliver a wide range of minimally invasive procedures, diagnostic imaging, lab tests, respiratory therapy, and rehabilitation therapy services all on one campus."
Clinical Trials at Genesys Regional Medical Center
During the past decade, Genesys Regional Medical Center conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 60 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 22 clinical trials were completed. i.e. 314.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Genesys Regional Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 21 trials, followed by "Alliance for Clinical Trials in Oncology" with 13 trials
sponsored, "Ascension Genesys Hospital" with 12 trials sponsored, "SWOG Cancer Research Network" with 10 trials sponsored and "Boston Scientific Corporation"
with 10 trials sponsored. Other sponsors include 41 different institutions and
companies that sponsored additional 37 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Genesys Regional Medical Center"
#1 collaborator was "National Cancer Institute (NCI)" with 37 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "Duke Clinical Research Institute" with 4 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 26 different institutions and companies that were
collaborators in the rest 33 trials.
Clinical Trials Conditions at Genesys Regional Medical Center
According to Clinical.Site data, the most researched conditions in "Genesys Regional Medical Center" are
"Breast Cancer" (8 trials), "Coronary Artery Disease" (8 trials), "Lung Cancer" (6 trials), "Recurrent Ovarian Carcinoma" (6 trials) and "Recurrent Fallopian Tube Carcinoma" (5 trials). Many other conditions were trialed in "Genesys Regional Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Genesys Regional Medical Center
Most popular intervention types in "Genesys Regional Medical Center" are "Drug" (69 trials), "Other" (40 trials), "Biological" (20 trials), "Device" (18 trials) and "Procedure" (11 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (17 trials), "Paclitaxel" (12 trials), "placebo" (9 trials), "Carboplatin" (8 trials) and "Quality-of-Life Assessment" (8 trials). Other intervention names were less common.
Clinical Trials Genders at Genesys Regional Medical Center
The vast majority of trials in "Genesys Regional Medical Center" are
81 trials for "All" genders, 28 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Genesys Regional Medical Center
Currently, there are NaN active trials in "Genesys Regional Medical Center".
undefined are not yet recruiting,
3 are recruiting,
20 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 67 completed trials in Genesys Regional Medical Center,
undefined suspended trials,
and 11 terminated clinical trials to date.
Out of the total trials that were conducted in Genesys Regional Medical Center, 2 "Phase 1"
clinical trials were conducted, 29 "Phase 2" clinical
trials and 41 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 10 trials, and there were
also 12 trials that are defined as “Not Applicable".